Re-framing the question: Should hydroxyethyl starch be used in clinical practice?
Open Access
- 7 November 2018
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 66 (1), 21-24
- https://doi.org/10.1007/s12630-018-1246-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Colloids versus crystalloids for fluid resuscitation in critically ill peopleCochrane Database of Systematic Reviews, 2018
- Should hydroxyethyl starch be banned?The Lancet, 2018
- Should hydroxyethyl starch be banned?The Lancet, 2018
- Should hydroxyethyl starch be banned?The Lancet, 2018
- Hydroxyethyl starch solutions and patient harmThe Lancet, 2018
- Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines AgencyJournal of Pharmaceutical Policy and Practice, 2017
- Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume ResuscitationJAMA, 2013
- Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive CareNew England Journal of Medicine, 2012
- Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe SepsisNew England Journal of Medicine, 2012
- Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisNew England Journal of Medicine, 2008